ABCG2 and acute myeloid leukemia: To investigate if expression of ABC transporters correlates with response to Venetoclax treatment in AML patients, we first quantified the expression of several ABC transporters that are relevant in AML in a cohort of samples from 16 patients prior to initiation of Venetoclax treatment.